| Open Label of Clinical Trial of Sulforaphane in Children With Autism | An Examination of Changes in Urinary Metabolites With Use of an Antioxidant Supplement, Sulforaphane, in School-aged Children With Autism | NCT02654743 |
| Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD) | Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD) | NCT02561481 |
| Effects of oral consumption of sulforaphane precursor-rich broccoli supersprouts on serum levels of advanced glycation end products in humans | Effects of oral consumption of sulforaphane precursor-rich broccoli supersprouts on serum levels of advanced glycation end products in humans - Effects of oral consumption of sulforaphane precursor-rich broccoli supersprouts on serum levels of advanced glycation end products in humans | JPRN-UMIN000018342 |
| Clinical Evaluation of the Efficacy of Dietary Sulforaphane on Male Fatty Liver Patients with Liver Dysfunction | Clinical Evaluation of the Efficacy of Dietary Sulforaphane on Male Fatty Liver Patients with Liver Dysfunction - Effect of sulforaphane on fatty liver with liver dysfunction | JPRN-UMIN000012855 |
| Effect of Sulforaphane on Prostate CAncer PrEvention | A Human Dietary Intervention Study to Investigate the Effect of Sulforaphane on Prostate Cancer Interception | NCT01950143 |
| Sulforaphane Supplementation in Atopic Asthmatics | Sulforaphane Supplementation in Atopic Asthmatics | NCT01845493 |
| An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia | Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia | NCT01716858 |
| Sulforaphane-rich Broccoli Sprout Extract for Autism | Sulforaphane-rich Broccoli Sprout Extract for Autism | NCT01474993 |
| Broccoli Sprout Extracts Trial to See if NRF2 is Enhanced by Sulforaphane Treatment in Patients With COPD | Enhancing Nrf2 by Sulforaphane Treatment in COPD | NCT01335971 |
| Sulforaphane in Treating Patients With Recurrent Prostate Cancer | The Effects of Sulforaphane in Patients With Biochemical Recurrence of Prostate Cancer | NCT01228084 |
| Effects of Sulforaphane on Normal Prostate Tissue | In Vivo Effects of Sulforaphane Supplementation on Normal Human Prostate | NCT00946309 |
| Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis | Effect of Topical Application of Sulforaphane- Containing Broccoli Sprout Extracts on Radiation Dermatitis During External-beam Radiation Therapy for Breast Cancer | NCT00894712 |
| Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS | Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers | NCT05233579 |
| Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions | Phase I Clinical Trial to Evaluate the Efficacy of Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions | NCT00621309 |
| A study on whether a natural sulforaphane supplement can boost glutathione levels | Evaluating the impact of a glucoraphanin and myrosinase supplement on glutathione levels: a randomized, placebo-controlled trial | ISRCTN15242244 |
| Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions | A Pilot Study Evaluation of Sulforaphane in Atypical Nevi--Precursor Lesions: Assessment of STAT1 and STAT3 Risk Markers of Melanoma | NCT01568996 |
| Clinical evaluation of the efficacy of dietary sulforaphane on lipid metabolism in postmenopausal women | Clinical evaluation of the efficacy of dietary sulforaphane on lipid metabolism in postmenopausal women - Effect of sulforaphane on lipid metabolism | JPRN-UMIN000022732 |
| Study of Sulphoraphane in Chronic Kidney Disease | Safety, Feasibility and Efficacy of Sulforaphane (Avmacol) in Chronic Kidney Disease | NCT05153174 |
| Effects of Sulforaphane for Patients With Chronic Kidney Disease | Salutary Effects of Sulforaphane for Patients With Chronic Kidney Disease | NCT04608903 |
| A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients | A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Negative Symptoms and Cognition Impairment of Schizophrenia Patients | NCT04521868 |
| Sulforaphane to Reduce Symptoms of Schizophrenia | A Double-Blind Placebo-Controlled Trial of a Sulforaphane Nutraceutical to Reduce the Symptoms of Schizophrenia | NCT02810964 |
| Treatment Strategy to Enhance Nrf2 Signaling in Older Adults | Treatment Strategy to Enhance Nrf2 Signaling in Older Adults: Combining Acute Exercise With the Phytochemical Sulforaphane | NCT04848792 |
| Investigation on the anti-inflammatory and antioxidant effects of sulforaphane to exercise | Investigation on the anti-inflammatory and antioxidant effects of sulforaphane to exercise - Exercise sulforaphane trial | JPRN-UMIN000045243 |
| Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults | "Sulforaphane-Smart® on Lipid and Glucose Metabolism, Inflammation, Adiposity and Microbiome of Overweight Adults ""SANO""" | NCT06964659 |
| Acute Intervention with Sulforaphane-Smart® | "Sulforaphane-Smart® on Lipid and Glucose Metabolism, Inflammation, Adiposity and Microbiome of Overweight Adults ""SANO""" | NCT06856486 |
| A 6-month Study to Evaluate Sulforaphane Effects in PD Patients | A 6-month Study to Evaluate Sulforaphane Effects in Treatment of Cognition Impairment of PD Patients | NCT05084365 |
| Sulforaphane as adjunctive treatment of irritability in children with Autism spectrum disorder | Sulforaphane treatment of autism spectrum disorder: a double blind controlled trial | IRCT20090117001556N107 |
| Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity | Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity | NCT06594536 |
| Validation Digital Bio-markers During Sulforaphane Treatment. | A Pilot Project to Validate Digital Bio-markers as a Tool to Measure Improvement in Core Symptoms of Autism During Sulforaphane Treatment. | NCT04805957 |
| Prevention and treatment of type 1 diabetes using natural compound sulforaphane | Targeting ferroptosis in diabetes and diabetic complications by hydrogen (per)sulfide in males 18 - 65 years old | ACTRN12624000972527 |
| Assessment of maternal-fetal transfer of sulforaphane and metabolites | Assessment of maternal-fetal transfer of sulforaphane and metabolites in umbilical cord blood and expressed breast milk | ACTRN12623000591651 |
| Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease | Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease - Randomized, Double-blind, Placebo-controlled Trial | NCT05797506 |
| Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease | Safety, Feasibility, and Tolerability of Sulforaphane in Children with CKD | NCT05653492 |
| Sulforaphane for the treatment of ADHD | Sulforaphane as an adjuvant therapy in children with attention-deficit/hyperactivity disorder (ADHD): A randomized, double-blind, placebo-controlled clinical trial | IRCT20090117001556N146 |
| The effect of sulforaphane on depression in women with PCOS | Evaluating the effect of sulforaphane supplementation in women with Polycystic ovary syndrome (PCOS) on depression, insulin resistance, and lipid profile change | IRCT20090117001556N144 |
| Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES | Prevention of Age-associated Cardiac and Vascular Dysfunction Through Nrf2 Signaling Using the Nutritional Supplement Sulforaphane | NCT05408559 |
| Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients | Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients | NCT05224492 |
| A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment | A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment | NCT05145270 |
| A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder | A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder | NCT05148169 |
| Comparison of broccoli sprout extracts in non-pregnant and pregnant women | Comparing broccoli sprout supplement formulations for circulating sulforaphane concentration in non-pregnant and pregnant women | ACTRN12623000592640 |
| The effect of Sulforaphane on the treatment of mild to moderate depression in post percutaneous coronary intervention patients | Sulforaphane as a treatment for mild to moderate depression in post percutaneous coronary intervention patients: A randomized double blind and placebo controlled clinical trial | IRCT20090117001556N128 |
| Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism | Sulforaphane in Autism: A Treatment Trial to Confirm Phenotypic Improvement With Sulforaphane Treatment in a New Jersey (NJ) Population of Individuals With Autism | NCT02677051 |
| Study on the absorption of sulforaphane after ingesting vegetable materials | Study on the absorption of sulforaphane after ingesting vegetable materials - Study on the absorption of sulforaphane after ingesting vegetable materials | JPRN-UMIN000039385 |
| The pharmacokinetics of two natural broccoli sprout supplements in healthy adults. | Evaluating the human pharmacokinetics (PK) of Sulforaphane from natural broccoli sprout supplements, a prospective, open label, exploratory cross over trial in healthy adults. | ACTRN12617000567325 |
| Clinical Evaluation of the Efficacy of Dietary Supplement "Sulforaphane" on Hepatic Function of Subjects | Clinical Evaluation of the Efficacy of Dietary Supplement "Sulforaphane" on Hepatic Function of Subjects - Effects of dietary supplement "Sulforaphane" on hepatic function | JPRN-UMIN000024017 |
| Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder | A Phase II, Randomized, Double-blind, Placebo-controlled Study of Myrosinase-enriched Glucoraphanin, a Sulforaphane Precursor System, in Autism Spectrum Disorder | NCT02909959 |
| Clinical Evaluation of the Effects of Dietary Sulforaphane on Sleep in Healthy Volunteers | Clinical Evaluation of the Effects of Dietary Sulforaphane on Sleep in Healthy Volunteers - Effects of Dietary Sulforaphane on Sleep | JPRN-UMIN000029141 |
| Sulforaphane Supplementation Study | Fatty Acid MetabOlism in Individuals Undergoing Sulforaphane Supplementation (FAMOUS) | NCT04364360 |
| Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention | Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention | NCT03517995 |
| The effects of Brain training and sulforaphane intake on cognitive functions and mental health in the elderly | The effects of Brain training and sulforaphane intake on cognitive functions and mental health in the elderly - The effects of Brain training and Sulforaphane intake | JPRN-UMIN000032624 |
| Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure | Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure | NCT03730649 |
| Pharmacokinetics of Sulforaphane from Natural Broccoli Sprout Supplements in Pregnancy. | Pharmacokinetics of Sulforaphane from Natural Broccoli Sprout Supplements in Pregnancy: a prospective, open label trial. | ACTRN12617001100381 |
| Broccoli in osteoarthritis | A dietary intervention trial to examine the effect of broccoli bioactives (specifically sulforaphane) on osteoarthritis (OA) | ISRCTN11629849 |
| Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) | Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial) | NCT03932136 |
| Accumulation of Dietary Bioactives and Prostate Cancer | A Pre-biopsy Window of Opportunity Trial to Measure the Dietary Bioactive Levels in the Prostate Following an Intervention With Sulforaphane and Allin Dietary Supplements | NCT04046653 |
| Comparative study on efficacy and safety of add-on sulforaphane, rTMS as antioxidant therapies for the treatment-resistant depression. | Comparative study on efficacy and safety of add-on sulforaphane, rTMS as antioxidant therapies for the treatment-resistant depression. | ChiCTR1900027063 |
| Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease | Randomized,Double-blind, Placebo-controlled, Efficacy and Safety Study of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease | NCT04213391 |
| A 12-weeks Study to Evaluate Sulforaphane in Treatment of Autism Spectrum Disorder | A 12-weeks, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Related Mechanism of Sulforaphane in Treatment of Autism Spectrum Disorder | NCT02879110 |
| A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia | Phase 2 Study of the Effect of add-on Sulforaphane in Treatment of Schizophrenia | NCT02880462 |
| A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression | Efficacy of Adjunctive Sulforaphane for Depression: Study Protocol for a Randomized, Double-blind, Placebo-controlled Study | NCT04246905 |
| Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage | Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage: Study Protocol for a Randomized Controlled Trial | NCT04252261 |
| Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction | Phase II Trial of Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction (CRI18-026) | NCT03934905 |
| Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers | Randomized Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers | NCT03232138 |
